Skip to main content

Table 5 Case study

From: CollaboNet: collaboration of deep neural networks for biomedical named entity recognition

  Chemical dataset  
Our STM No prophylaxis with antilymphocyte globulin was used - globulin : Protein
CollaboNet No prophylaxis with antilymphocyte globulin was used  
Ground Truth No prophylaxis with antilymphocyte globulin was used  
Our STM elderly patients using ACE / ARB in combination with potassium ACE : Gene/Protein
CollaboNet elderly patients using ACE / ARB in combination with potassium  
Ground Truth elderly patients using ACE / ARB in combination with potassium  
  Disease Dataset  
Our STM The ATM (A-T, mutated) gene on human chromosome 11q22. A-T, mutated : Gene
CollaboNet The ATM (A-T, mutated) gene on human chromosome 11q22.  
Ground Truth The ATM (A-T, mutated) gene on human chromosome 11q22.  
Our STM to bind to the human cardiac troponin T (cTNT) pre-messenger RNA cTNT : Gene/Protein
CollaboNet to bind to the human cardiac troponin T (cTNT) pre-messenger RNA  
Ground Truth to bind to the human cardiac troponin T (cTNT) pre-messenger RNA  
  Gene / Protein Dataset  
Our STM which is inhibited by the cytotoxin leptomycin B (LMB), and also by its interaction LMB : Chemical, Drug
CollaboNet which is inhibited by the cytotoxin leptomycin B (LMB), and also by its interaction  
Ground Truth which is inhibited by the cytotoxin leptomycin B (LMB), and also by its interaction  
Our STM Classic Hodgkin disease (cHD) is derived from B cells with high loads of mutations. cHD : Disease
CollaboNet Classic Hodgkin disease (cHD) is derived from B cells with high loads of mutations  
Ground Truth Classic Hodgkin disease (cHD) is derived from B cells with high loads of mutations  
  1. This table contains sentences that were incorrectly predicted by of our STM but were correctly predicted by CollaboNet. The predicted labels or the ground truth labels are underlined